RMC-6291 CAS No.2641998-63-0
RMC-6291 CAS No.2641998-63-0
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-R-2975 | 1mg | 410.00 | + Add to cart  | 
																					|
| R-R-2975 | 2mg | 710.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							RMC-6291/CAS No.2641998-63-0 is an orally active and covalent inhibitor of KRASG12C(ON). RMC-6291 forms a tri-complex within tumor cells between KRASG12C(ON) and cyclophilin A (CypA). Thus, RMC-6291 prevents KRASG12C(ON) from signaling via steric blockade of RAS effector binding. RMC-6291 inhibits ERK signaling and induced apoptosis in KRASG12C-mutant H358 cells. RMC-6291 also inhibits the proliferation of KRASG12C mutant cells with a median IC50 of 0.11 nM.
								| Appearance | N/A | 
|---|---|
| Molecular Weight | 1012.00 | 
| Purity | >90% | 
| CAS | 2641998-63-0 | 
| Formula | C55H78FN9O8 | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 2 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds of RMC-6291 CAS No.2641998-63-0 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

